lupus and glp 1 weight-loss-medicines-lupus-ozempic-wegovy-mounjaro-zepbound Glucagon-like peptide-1 receptor agonists in

In a statement, Novo Nordisk said the rapprochement between the two companies is "a meaningful win for patients in the US" and will expand access to Ozempic and Wegovy, adding that the two products have been "evaluated for safety and efficacy." The company also said that it "welcomes Hims & Hers shifting their GLP-1 business model to focus on increasing access to affordable, branded FDA-approved medicines." It has also agreed to drop its lawsuit with Hims & Hers that followed the compounded oral semaglutide announcement

This dual action on both glycemic control and cardiovascular health has elevated GLP-1 receptor agonists to an important position in diabetes management

After an evaluation, he came up with a plan for me to get out of pain and back to my normal activities as quick as possible

ArticlePubMedPMC 10